| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |